Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Tepezza™ (teprotumumab-trbw) – New orphan drug approval
January 21, 2020 - The FDA announced the approval of Horizon Therapeutics’ Tepezza (teprotumumab-trbw), for the treatment of thyroid eye disease (TED).
